Medilux Laboratories Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 26-07-2024
- Paid Up Capital ₹ 5.50 Cr
as on 26-07-2024
- Company Age 39 Year, 7 Months
- Last Filing with ROC 31 Mar 2016
- Open Charges ₹ 55.98 Cr
as on 26-07-2024
- Satisfied Charges ₹ 2.26 Cr
as on 26-07-2024
About Medilux Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 5.50 Cr.
The company currently has active open charges totaling ₹55.98 Cr. The company has closed loans amounting to ₹2.26 Cr, as per Ministry of Corporate Affairs (MCA) records.
Deepak Kewalramani, Sunil Kewalramani, Satish Matkar, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232MP1985PTC002843
- Company No.
002843
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Apr 1985
- Date of AGM
29 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Medilux Laboratories Pvt Ltd offer?
Medilux Laboratories Pvt Ltd offers a wide range of products and services, including .
Who are the key members and board of directors at Medilux Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Kewalramani  | Managing Director | 03-Aug-1990 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjay Kewalramani | Director | 25-May-2011 | Current |
| Sunil Kewalramani | Director | 01-Sep-2009 | Current |
| Satish Matkar | Director | 01-May-2007 | Current |
Financial Performance of Medilux Laboratories.
Medilux Laboratories Pvt Ltd, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Medilux Laboratories?
In 2018, Medilux Laboratories had a promoter holding of 100.01%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medilux Healthcare Private LimitedActive 13 years 4 monthsDeepak Kewalramani and Sanjay Kewalramani are mutual person
- Medilux Diagnostics Private LimitedActive 13 years 4 months
Deepak Kewalramani and Sanjay Kewalramani are mutual person
Medilux Pharma LlpActive 3 years 3 monthsDeepak Kewalramani and Sanjay Kewalramani are mutual person
- Deepaksan Tradex LlpActive 1 year 11 months
Deepak Kewalramani and Sanjay Kewalramani are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Nov 2016 | ₹7.50 M | Open |
Others Creation Date: 28 Nov 2016 | ₹2.20 Cr | Open |
Others Creation Date: 31 Aug 2016 | ₹1.60 Cr | Open |
How Many Employees Work at Medilux Laboratories?
Medilux Laboratories has a workforce of 373 employees as of Jul 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medilux Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medilux Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
